Catalyst Wire Dossier Catalyst Wire Dossier

Tazorac (tazarotene) cream, 0.1%

tazarotene · AbbVie (Allergan Pharmaceuticals, historically) / licensed as Tazorac
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tazorac (tazarotene) cream, 0.1%, covering 2018-08-17 to 2020-08-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris [Phase 2]

See pricing